SBIR/STTR Research Award

Modification of Polymer Surfaces using a Femtosecond Laser to Prevent Bacteria Colonization in Endotracheal Tubes

Award identifier a574f547188c862cf4cdd1ed86fb467de48939e4b79bac808d61bd05b7d4e835Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$296,186

Program and phase

SBIR · Phase I

Award year

2019

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ACTUATED MEDICAL, INC.
Proposal award date
2019-01-15
Contract end date
2020-12-31
UEI
VG84D4KN5LR5
Solicitation number
PA18-574
Topic code
NHLBI

Research abstract

This Phase I SBIR develops and tests an approach for Modification of Polymer Surfaces using a Femtosecond Laser to Prevent Bacteria Colonization in Endotracheal TubesProblem to be solvedThe Centers for Disease Control reports that more thanmillion people in the U Sare infected by antibiotic resistant bacteriaARBannuallywith estimated direct healthcare costs near $billionMorbiditymortalityand care costs are expected to parallel the upward trend of bacterial virulence and antibiotic resistanceMany common support devicessuch as endotracheal tubesETTscentral venous cathetersand nasoenteric feeding tubesare prone to infiltration by microbesETTswith overM annual in patient intubationsinrepresent a major risk areasince the rate of ventilator associated pneumoniaVAPisof patientsand in the intensive care unit VAP is the most common and fatal infectionRisk mitigation methodssuch as aseptic techniquesare limited by complianceand antiseptics and antibioticsthough often effectivecan have unintended effects on bacteria resilience and environmental toxicityAn approach is needed that produces long term bacteria inactivation around and inside support devices without the use of unsafe chemicalsGap in KnowledgeModifying surface texture and chemistry has had mixed results in killing bacteriaActuated MedicalIncAMIproposes that a primary reason for inconsistent outcomes is difficulty using viable methods for producing ideal topography with conventional substrates for the clinical applicationAMI will use its expertise in medical devicespolymersand endotracheal tubesand collaborate with an immunology expert from The Pennsylvania State University and laser machining experts from Laser for Innovative Solutions Inc to demonstrate an ETT surface structure capable of chemical freebactericidal action on three prevalent microbes that cause ventilator associated nosocomial infectionsPhase I HypothesisLaser surface patterning of ETT prototype demonstrates significantly less viable ventilator associated bacterial load overhour exposures in vitroSpecific AimsAimDemonstrate high qualityD nano patterning on medical polymersAcceptance CriteriaAbility to patterncmarea withnm featuresas confirmed with scanning electron microscopythat maintainintegrity after exposure to realistic ventilation conditionsAimDetermine optimum bactericidal surface preparation sfor relevant microbes through design of experimentAcceptance CriteriaAt least one surface preparation shows at leastlogfewer viable colony forming unitsCFUsof PaeruginosaSaureusand Abaumannii relative to control surfacesAimDemonstratelog bacteria reduction in ETT form factorAcceptance CriteriaETT tube section with optimized laser pattern maintains at leastlogfewer colony forming units of bacteria overhours relative to control surfaces in biofilm inducing conditions in vitro Project NarrativeRelevanceThe Centers for Disease Control reports that more thanmillion people in the U Sare infected by antibiotic resistant bacteria annuallywith estimated direct healthcare costs near $billionMorbiditymortalityand care costs are expected to parallel the upward trend of bacterial virulence and antibiotic resistanceMany common support devicessuch as endotracheal tubesETTscentral venous cathetersand nasoenteric feeding tubesare prone to infiltration by microbesModifying surface texture and chemistry has had mixed results in killing bacteriaThis project will build a microbicidal barrierspecific for ETT bacteriaon the distal and proximal ends of the ETTboth inside and outside the tube

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

53 SBIR/STTR records share this UEI (2008–2024). Reported award amounts total $43,582,989. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation, Department of Defense, National Aeronautics and Space Administration, Department of Agriculture

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.